Gores GJ - Search Results

1

Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.

Ponsioen CY, Chapman RW, Chazouillères O, Hirschfield GM, Karlsen TH, Lohse AW, Pinzani M, Schrumpf E, Trauner M, Gores GJ. Ponsioen CY, et al. Among authors: gores gj. Hepatology. 2016 Apr;63(4):1357-67. doi: 10.1002/hep.28256. Epub 2015 Dec 23. Hepatology. 2016. PMID: 26418478 Review.

2

Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.

Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE, Wahlstrom HE, Krom RA. Wiesner RH, et al. Among authors: gores gj. Hepatology. 1992 Nov;16(5):1290-9. Hepatology. 1992. PMID: 1427667 Review.

3

Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue.

Sandborn WJ, Lawson GM, Cody TJ, Porayko MK, Hay JE, Gores GJ, Steers JL, Krom RA, Wiesner RH. Sandborn WJ, et al. Among authors: gores gj. Hepatology. 1995 Jan;21(1):70-6. Hepatology. 1995. PMID: 7528712 Clinical Trial.

4

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study.

Lindor KD, Dickson ER, Jorgensen RA, Anderson ML, Wiesner RH, Gores GJ, Lange SM, Rossi SS, Hofmann AF, Baldus WP. Lindor KD, et al. Among authors: gores gj. Hepatology. 1995 Oct;22(4 Pt 1):1158-62. doi: 10.1016/0270-9139(95)90624-x. Hepatology. 1995. PMID: 7557866 Clinical Trial.

5

Apoptosis and hepatobiliary disease.

Patel T, Gores GJ. Patel T, et al. Among authors: gores gj. Hepatology. 1995 Jun;21(6):1725-41. doi: 10.1002/hep.1840210635. Hepatology. 1995. PMID: 7768518 Review.

6

Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation.

Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Buckel EG, Steers JL, Wiesner RH, Krom RA. Sanchez-Urdazpal L, et al. Among authors: gores gj. Hepatology. 1993 Apr;17(4):605-9. doi: 10.1002/hep.1840170413. Hepatology. 1993. PMID: 8477965

7

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.

Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, McGill DB. Laurin J, et al. Among authors: gores gj. Hepatology. 1996 Jun;23(6):1464-7. doi: 10.1002/hep.510230624. Hepatology. 1996. PMID: 8675165

8

Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?

Harnois DM, Gores GJ, Ludwig J, Steers JL, LaRusso NF, Wiesner RH. Harnois DM, et al. Among authors: gores gj. J Hepatol. 1997 Sep;27(3):512-6. doi: 10.1016/s0168-8278(97)80356-x. J Hepatol. 1997. PMID: 9314129 Clinical Trial.

9

Death receptors in liver biology and pathobiology.

Faubion WA, Gores GJ. Faubion WA, et al. Among authors: gores gj. Hepatology. 1999 Jan;29(1):1-4. doi: 10.1002/hep.510290101. Hepatology. 1999. PMID: 9862841 Review. No abstract available.

10

Recurrence of primary sclerosing cholangitis following liver transplantation.

Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, Hay JE, Gores GJ, Charlton MR, Ludwig J, Poterucha JJ, Steers JL, Krom RA. Graziadei IW, et al. Among authors: gores gj. Hepatology. 1999 Apr;29(4):1050-6. doi: 10.1002/hep.510290427. Hepatology. 1999. PMID: 10094945 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

688 results

Search Page